Market Indices
Sector Heatmap
AZN — AstraZeneca PLC
NYSEAstraZeneca PLC
- O
- 158.46
- H
- 158.80
- L
- 156.41
- V
- 2.64M
AZN — Latest News & Headlines
20 StoriesAstraZeneca PLC (AZN.L) Stock Price, News, Quote & History - Yahoo! Finance Canada
AstraZeneca PLC (AZN.L) Stock Price, News, Quote & History Yahoo! Finance Canada
AstraZeneca PLC (AZN) Stock Down 1.2% -- Now Undervalued? GF Sco - gurufocus.com
AstraZeneca PLC (AZN) Stock Down 1.2% -- Now Undervalued? GF Sco gurufocus.com
AstraZeneca and two partners plan to test a cancer-drug pairing in breast cancer - Stock Titan
AstraZeneca and two partners plan to test a cancer-drug pairing in breast cancer Stock Titan
Analysts back AstraZeneca's $2B Summit Therapeutics investment as stock gains (AZN:NYSE) - Seeking Alpha
Analysts back AstraZeneca's $2B Summit Therapeutics investment as stock gains (AZN:NYSE) Seeking Alpha
AstraZeneca (LSE:AZN) Stock May Be 48% Undervalued On Enhertu Trial Progress - Yahoo Finance
AstraZeneca (LSE:AZN) Stock May Be 48% Undervalued On Enhertu Trial Progress Yahoo Finance
A $2 Billion Reason Why AstraZeneca Stock Is Down Today - Barchart.com
A $2 Billion Reason Why AstraZeneca Stock Is Down Today Barchart.com
Employee schemes bring 9,828 new AstraZeneca (AZN) shares to London Stock Exchange trading. - Stock Titan
Employee schemes bring 9,828 new AstraZeneca (AZN) shares to London Stock Exchange trading. Stock Titan
Why AstraZeneca Still Looks Underrated Despite Strong EPS Momentum (NYSE:AZN) - Seeking Alpha
Why AstraZeneca Still Looks Underrated Despite Strong EPS Momentum (NYSE:AZN) Seeking Alpha
Astrazeneca (AZN) Ascends But Remains Behind Market: Some Facts to Note - Yahoo Finance
Astrazeneca (AZN) Ascends But Remains Behind Market: Some Facts to Note Yahoo Finance
AstraZeneca and Summit plan to study two cancer treatments together in digestive cancers. - Stock Titan
AstraZeneca and Summit plan to study two cancer treatments together in digestive cancers. Stock Titan
AstraZeneca granted EU label expansion for COPD therapy, Trixeo in asthma - Seeking Alpha
AstraZeneca granted EU label expansion for COPD therapy, Trixeo in asthma Seeking Alpha
AstraZeneca (AZN): Can Precision Medicine Offset a Narrower Breast Cancer Market? - Yahoo Finance
AstraZeneca (AZN): Can Precision Medicine Offset a Narrower Breast Cancer Market? Yahoo Finance
With no treasury shares, AstraZeneca (AZN) reports 1.55B voting rights. - Stock Titan
With no treasury shares, AstraZeneca (AZN) reports 1.55B voting rights. Stock Titan
Is AstraZeneca (LSE:AZN) Undervalued Following Its New Lung Cancer FDA Filing? - Yahoo Finance
Is AstraZeneca (LSE:AZN) Undervalued Following Its New Lung Cancer FDA Filing? Yahoo Finance
Rights equivalent to a 12% stake await closing as AstraZeneca (AZN) agrees to invest in Summit. - Stock Titan
Rights equivalent to a 12% stake await closing as AstraZeneca (AZN) agrees to invest in Summit. Stock Titan
Astellas Pharma (TSE:4503) Stock Could Be 39% Below Fair Value On Cash Flow - Yahoo Finance
Astellas Pharma (TSE:4503) Stock Could Be 39% Below Fair Value On Cash Flow Yahoo Finance
Lung and breast cancers are targets of AstraZeneca (AZN)'s new three-company trial collaboration. - Stock Titan
Lung and breast cancers are targets of AstraZeneca (AZN)'s new three-company trial collaboration. Stock Titan
Astrazeneca (AZN) Registers a Bigger Fall Than the Market: Important Facts to Note - sg.finance.yahoo.com
Astrazeneca (AZN) Registers a Bigger Fall Than the Market: Important Facts to Note sg.finance.yahoo.com
AZN vs. MRK: Comparing Keytruda, Pipelines and Growth Strategies - Yahoo Finance
AZN vs. MRK: Comparing Keytruda, Pipelines and Growth Strategies Yahoo Finance
Is AstraZeneca's Oncology Portfolio Positioned for Continued Growth? - Yahoo Finance
Is AstraZeneca's Oncology Portfolio Positioned for Continued Growth? Yahoo Finance